<DOC>
	<DOCNO>NCT01050647</DOCNO>
	<brief_summary>Preterm birth lead cause neonatal death significant cause life long disability health problem . It show drug 17-hydroxyprogesterone caproate help reduce risk preterm delivery woman certain risk factor preterm birth . We hope learn whether medication use prolong pregnancy group patient medication previously study . Specifically , hope learn whether progesterone supplementation delay delivery woman pre-term , premature rupture membrane ( PPROM ) .</brief_summary>
	<brief_title>Progesterone Management Preterm , Premature Rupture Membranes : A Randomized Controlled Trial .</brief_title>
	<detailed_description>When woman present either Obstetrical clinic labor delivery complaint possible preterm , premature rupture membrane ( PPROM ) , examine obstetrician either confirm rule diagnosis . If diagnose PPROM , admit Lucile Packard Children 's Hospital treat normal protocol include receive antibiotic , receive steroid , hospitalize delivery , ongoing maternal fetal monitoring possible complication . The patient identify treat obstetrician possible study candidate ask member treatment team potentially interested participate research study . Subsequently , member study team treat physician approach patient participate trial . Those choose participate receive standard care protocol addition receive study medication . The study medication weekly injection either placebo 17-hydroxyprogesterone caproate placebo . The placebo medication ( castor oil ) chosen use previous study placebo 17-hydroxyprogesterone caproate . The choice medication patient receives determine randomization table . Only pharmacist aware medication administer . The patient , member treatment team , member study team blind medication administer . The timing delivery manage treat obstetrician accord standard medical practice . After delivery , patient 's infant 's medical outcome record analysis .</detailed_description>
	<mesh_term>Rupture</mesh_term>
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Castor Oil</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>17-alpha-hydroxy-progesterone caproate</mesh_term>
	<mesh_term>11-hydroxyprogesterone</mesh_term>
	<criteria>1 . 18yr age 2 . Singleton pregnancy 3 . PPROM confirm clinical exam 4 . GA 24+0 33+5 wk 5 . Ability understand consent either English Spanish 1 . Contraindication ongoing pregnancy include : 1 . Evidence active infection 2 . Evidence significant placental abruption 3 . IUFD diagnose time PPROM diagnosis 2 . Major fetal malformation 3 . Maternal allergy progesterone placebo drug component 4 . Current use progesterone time PPROM 5 . Multiple Gestations 6 . Inability understand consent either English Spanish</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>